ArticlePakistan journal of medical sciences2025
Risk factors for major cardiovascular adverse events and the effects of sacubitril/valsartan in patients with acute myocardial infarction after Percutaneous Coronary Intervention.
Yang Peng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.